Michael Floyd - 09 Feb 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
09 Feb 2023
Transactions value $
$8,000
Form type
4
Filing time
10 Feb 2023, 16:22:45 UTC
Previous filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $8,000 +10,000 +13.84% $0.8 82,267 09 Feb 2023 Direct
holding PCSA Common Stock 89,794 09 Feb 2023 by Elion Oncology, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.